Simple and straightforward construction of a mouse gene targeting vector using in vitro transposition reactions by Aoyama, Minako et al.
Simple and straightforward construction of a mouse
gene targeting vector using in vitro transposition
reactions
Minako Aoyama, Kazuko Agari, Ge-Hong Sun-Wada, Masamitsu Futai
1 and Yoh Wada*
Division of Biological Science, Institute for Scientific and Industrial Research, Osaka University and CREST,
Japan Science and Technology Agency, Mihogaoka 8-1, Ibaraki, Osaka 567-0047, Japan and
1Futai Special
Laboratory, Microbial Chemistry Research Center, Microbial Chemistry Research Foundation and CREST,
Japan Science and Technology Agency, 3-14-23 Kamiosaki, Shinagawa-ku, Tokyo 141-0021, Japan
Received February 3, 2005; Revised and Accepted March 7, 2005
ABSTRACT
In a gene targeting experiment, the generation of
a targeting construct often requires complex DNA
manipulations. We developed a set of cassettes and
plasmids useful for creating targeting vectors to
modify the mammalian genome. A positive selection
markercassette(PGK/EM7p-npt),whichincludeddual
prokaryotic and eukaryotic promoters to permit con-
secutive selection for recombination in Escherichia
coli and then in mouse embryonic stem cells,
was flanked by two FRT-loxP sequences. The PGK/
EM7p-npt cassette was placed between the minimum
regions of a Tn7 transposable element for insertion
intoanotherDNAbymeansofTn7transposaseinvitro.
We also constructed a plasmid having a loxP-Zeo-
loxP cassette between the modified Tn5 outer ele-
ments. These cassettes can be integrated randomly
into a given genomic DNA through the in vitro trans-
position reaction, thus producing a collection of
genomic segments flanked by loxP sites (floxed) at
various positions without the use of restriction
enzymes and DNA ligase. We confirmed that this sys-
tem remarkably reduced the time and labor for
the construction of complex gene targeting vectors.
INTRODUCTION
Gene targeting is a powerful method for producing genetically
modiﬁed animals to study gene function in vivo. This powerful
technology allows us to introduce designed mutations into
any cloned locus, and to analyze generated mice with the
corresponding genetic changes. The resulting phenotypes
often provide an insight into the functions of genes. However,
a gene targeting experiment is laborious and time-consuming,
demanding elaborate techniques for the manipulation of DNA,
cells and embryos, and it often takes more than one year from
the design of constructs to generation of animals.
Replacement of the native gene with a modiﬁed gene frag-
ment in the mammalian genome by homologous recombina-
tion is performed to introduce genetic alteration in embryonic
stem (ES) cell. One of the limiting steps is the generation of
‘gene targeting vectors’, since the design of a targeting vector
must fulﬁll several requirements. First, efﬁcient homologous
recombination in the ES genome requires fairly long (>5 kb,
>10 kb, if possible) homologous segments ﬂanking the altera-
tion in the targeting construct (1–4). The use of a positive
selection marker is mandatory for selecting candidates having
homologous replacement, and it should be placed in a proper
region and be designed to be removable afterward. For this
purpose,the loxP/Cre (4)andFRT/FLPe (5)systemshave been
used to remove the selective markers in ES cells or animals.
The use of these highly speciﬁc recombination systems also
led to the second generation gene modiﬁcation strategy for
controlling genetic alterations spatio-temporally in animals
(6,7). However, the design and construction of ﬂoxed alleles
islabor-intensive. TheloxPsitesmustbeplaced atbothendsof
the genomic segments to be deleted upon Cre recombinase-
mediated recombination, but reasonably far from the ends of
the construct for efﬁcient homologous recombination in the
ES genome. They must be placed in intron regions to conserve
the structure and function of the gene products. In addition,
genomic regions containing highly repetitive elements should
be excluded from the targeting construct, since these elements
hamper efﬁcient and accurate detection of homologous
recombination on PCR or Southern hybridization analyses.
The mouse genome project allows us to deduce the struc-
tures of loci of interest at the nucleotide sequence level
in silico. We searched for single restriction sites that fulﬁll
the requirements described above, and then synthesized loxP
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and integrated them into the targeting vector by using DNA
ligase. However, it is not always straightforward to ﬁnd an
appropriate unique recognition site within a given genomic
segment. Even when a suitable restriction site exists, it still
remains difﬁcult to introduce only a single short loxP segment
( 40 bp) into a large plasmid (>10 kb) by conventional DNA
manipulation relying on T4 DNA ligase.
To overcome these limitations, we applied bacterial trans-
poson systems to simplify the construction of complex target-
ing vectors. Bacterial transposon exhibits minimal sequence
preference for their insertions and single insertions within a
several hundred kilo base pairs region of a single molecule
due to their long-range cis interactions (8). These features can
be reconstituted in vitro (9–11). The nature of the in vitro
transposition reactions is very powerful for assembling com-
plextargetingconstructs,asreportedpreviously(12).Here, we
developed a set of plasmids that signiﬁcantly reduce the time
and labor for the construction of gene targeting constructs.
We described a typical experiment for modiﬁcation of the
mouse mVam2/Vps41 gene as a model study.
MATERIALS AND METHODS
Antibiotics and bacteria culture
E.coli was cultured in Terriﬁc Broth. Ampicillin sodium salt
(Amp), kanamycin sulphate (Kan), chloramphenicol (Chl),
tetracycline HCl (Tet) and Zeocin (Zeo) were used at concen-
trations of 100, 25, 33, 12.5 and 100 mg/ml, respectively. BAC
DNA was prepared with a Qiagen large construction kit, and
plasmid DNA was prepared with an automated DNA isolation
system, PI-50a (KURABO), following the manufacturer’s
recommendations.
Assembly of pGPS21loxFRTNeo
Plasmid pLox-neo, a PGKp-npt-pA DNA cassette with two
loxP sequences in pBluescript II SK
+, was a generous gift from
Drs Osamu Minowa and Tetsuo Noda. Insertion of a synthetic
EM7promoter(EM7p)forprokaryoteswascarriedoutby site-
directed mutagenesis (13) with modiﬁcations as follows. The
EM7p sequence with homology arms for the PGK promoter
(PGKp) region was ampliﬁed from an EM7p-containing
plasmid, pVgRXR (Invitrogen), by PCR using primer pair
PGKEM7S and PGKEM7A (Table 1). The PCR product
was annealed to a single-stranded DNA of pLox-neo prepared
from an E.coli dut
  ung
  strain co-infected with M13 KO7
helper phage, and then transformed into a dut
+ ung
+ strain
followed by selection for ampicillin and kanamycin. Plasmids
were recovered and then sequenced to verify the loxP-PGK/
EM7p-npt-loxP region to obtain pLoxPGKEM7-Neo.
FRT sequences were inserted into unique HindIII (between
the upstream loxP and PGKp) and EcoRI (between the down
stream loxP and vector backbone) sites in two steps. First,
an FRT segment with HindIII sites at both ends was prepared
from yeast 2 mm ori containing plasmid YEp24 by PCR with
primers HindFLP-A1 and HindFLP-S1, and then inserted at
theHindIIIsiteofpLoxPGKEM7-Neotoyieldanintermediate
plasmid. Second, an EcoRI-FRT-EcoRI segment was prepared
using primer pair EcoFLP-S1 and EcoFLP-A1, and then
inserted at the EcoRI site of the intermediate plasmid. The
orientations of the two FRT segments were veriﬁed by sequen-
cing, and a correctly conﬁgured plasmid, pLoxFRTNeo-1
was obtained. pLoxFRTNeo-1 was digested with XhoI and
SmaI, polished with T4 DNA polymerase, then subcloned
into the SpeI–NotI sites (trimmed with T4 DNA polymerase)
of pGPS2.1 (New England Biolabs), introduced into E.coli
strain EC100D pir-116 (Epicentre), and then selected on
tetracyclin and kanamycin to obtain the ﬁnal construct,
pGPS21loxFRTNeo.
Assembly of pMODloxZeoDamp3
A loxP-Zeo-loxP DNA segment was ampliﬁed with a primer
pair ERVloxSR-5 and ERVloxSV40-3 using pVgRXR
(Invitrogen) as a template. The PCR product, having a loxP
sequence at the both end, a mammalian enhancer/promoter,
the EM7 promoter and Zeo
R, was digested with EcoRV and
then introduced into the ClaI/HindIII sites (ﬂushed with
T4 DNA polymerase) of pMOD<MCS> (Epicentre) to yield
pMODloxZeo-1. The bla gene of the pMODloxZeo-1 was
disrupted by digestion with ScaI and SspI, and trimmed
with T4 DNA polymerase, and then a part of mammalian
transcriptional element was removed by SphI and PstI diges-
tion to obtain a ﬁnal plasmid, pMODloxZeoDamp3.
Table 1. List of oligonucleotides used in this study
Primer name Sequence
PGKEM7S 50-CCTCTTCCTCATCTCCGGGCCTTTCGACCTGTTGACAATTAATCATCGGC-30
PGKEM7A 50-GCAATCCATCTTGTTCAATGGCCGATCCCATGGTGGCCCTCCTATAGTGA-30
HindFLP-S1 50-TCAAAAGCTTTCTGAAGTTCCTATACTTTC-30
HindFLP-A1 50-CGGAAAAGCTTTGAAGTTCCTATTCCGAAG-30
EcoFLP-S1 50-TCAAAAGAATTCTGAAGTTCCTATACTTTC-30
EcoFLP-A1 50-CGGGAATTCTTTGAAGTTCCTATTCCGAAG-30
ERVloxSR-5 50-GGGATATCATAACTTCGTATAATGTATGCTATACGAAGTTATGTGTGTCAGTTAGGGTGT-30
ERVloxSV40-3 50-CCGATATCATAACTTCGTATAGCATACATTATACGAAGTTATCCAGACATGATAAGATAC-30
loxzeo-Cla 50-CCCTAACTGACACACATAACTTCGTAT-30
loxzeo-Nsi 50-ACTCATCAATGCATCTTATCATGTCT-30
PmeRsr1 50-GTTTAAACGGACCGC-30
PmeRsr2 50-GGTCCGTTTAAACAGCT-30
FseSrf1 50-CTAGGATCCGGCCGGCCCGGGC-30
FseSrf2 50-GATCGCCCGGGCCGGCCGGATC-30
M13 Fwd23 50-CCCAGTCACGACGTTGTAAAACG-30
DT-AR 50-ACTACTGATTCTAATTGTTTGTGT-30
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A HincII–XhoI segment of the MC-1 promoter and DT-A
region was excised from pMC1DT-A (LifeTec) and inserted
into pBluescript II SK
  to obtain pBSDT-A. A pair of syn-
thetic oligonucleotides, PmeRsr1 and PmeRsr2 (Table 1), was
annealed to obtain a linker, which was then inserted at
the SacI–SacII sites of pBSDT-A, and then a second linker
(a duplex of FseSrf1 and FseSrf2, see Table 1) was introduced
at the BamHI–XbaI sites to generate pBSDT-AII. The struc-
ture of multiple cloning site of pBSDT-AII was veriﬁed by
sequencing.
In vitro transposition reactions
In vitro transposition reaction of pGPS21loxFRTNeo and
pMODloxZeoDamp was performed with TnsABC* (New
England Biolabs) and EZ::Tntransposase (Epicentre), respect-
ively, following the manufacturer’s instructions. The reaction
product was puriﬁed by phenol/chloroform extraction and
ethanol precipitation, and then introduced into an appropriate
E.coli strain by electroporation.
RESULTS AND DISCUSSION
Construction of a transposable KAN/G418 cassette
with loxP and FRT sequences
Plasmid pGPS21loxFRTNeo (Figure 1) was designed to intro-
duce a positive selection marker into gene segments by in vitro
transposition reaction. This plasmid has several unique fea-
tures. The Tn5-derived neomycin phosphotransferase gene
(npt) was placed downstream of a short fragment of the EM7
promoter (EM7p) and mammalian PGK promoter (PGKp)
sequence.ThisDNAfragmentconferred kanamycinresistance
(5–50 mg/ml) on E.coli and G418 resistance (100–300 mg/ml)
on mouse ES cells, respectively (data not shown), indicating
that the PGK/EM7p-npt segment could be used as a positive
selection marker in E.coli as well as ES cells.
This PGK/EM7p-npt segment is placed between the right
and left borders of the Tn7 transposing element, therefore
it can be inserted into other DNAs by incubation with a com-
mercially available Tn7 transposase. Upon Flpe-mediated
recombination (14), this selectable marker can be removed,
leaving one loxP site. The border sequences were placed out-
side of the two FRT-loxP sequences, therefore transposition
introduces a segment of FRT-loxP-PGK/EM7p-npt-FRT-
loxP into the target DNA. In vitro transposition events take
place almost randomly, and multiple insertions into the
same DNA fragment are rare due to the target immunity
(8). Plasmid pGPS21loxFRTNeo has R6Kg replication ori,
and common E.coli strains like DH10B and XL1-Blue are
not able to maintain this plasmid, but it replicates as a multiple
copy plasmid in bacteria expressing the pir-116 protein.
Construction of a transposable cassette with
a loxP-Zeo-loxP segment
Another plasmid,pMODloxZeoDamp3(Figure2),which hasa
loxP-Zeo-loxP cassette between modiﬁed Tn5 outer elements,
was constructed to facilitate the third loxP element insertion.
Tn5 and Tn7 require individual machineries for their trans-
position and both elements can be introduced in the cis con-
ﬁguration. pMODloxZeoDamp3 has a pUC/Col E1 replication
origin, a disrupted ampicillin-resistance gene, and a functional
EM7-driven Zeocin-resistance gene, and thus confers Zeo
R on
common laboratory strains of E.coli.
pGPS21loxFRTNeo
(5630 bp)
FRT
loxP
PGKp
Tn7L
npt
FRT
loxP
Tn7R
Tetr
R6Kγ ori
EM7p
Tn7 right border 
//---TTCTTCTGAggggatccgctgtaagtctgcagaaattgatgatctattaaacaataaagatgtccactaaaat
// -  F  F  *
ggaagtttttcctgtcatactttgttaagaagggtgagaacagagtacctacattttgaatggaaggattggagcta
cgggggtgggggtggggtgggattagataaatgcctgctctttactgaaggctctttactattgctttatgataatg
tttcatagttggatatcataatttaaacaagcaaaaccaaattaagggccagctcattcctcccactcatgatctat
agatctatagatctctcgtgggatcattgtttttctcttgattcccactttgtggttctaagtactgtggtttccaa
atgtgtcagtttcatagcctgaagaacgagatcagcagcctctgttccacatacacttcattctcagtattgttttg
ccaagttctaattccatcagAAGCTGGTCGAGATAACTTCGTATAATGTATGCTATACGAAGTTATAGGATCCGGCC
GATCGAATTCTGAAGTTCCTATACTTTCTAGAGAATAGGAACTTCGGAATAGGAACTTCAAAGAATTCCTGCAGCCC
GGGACCCCACGCCCCTCTTTAATACGACGGGCAATTTGCACTTCAGAAAATGAAGAGTTTGCTTTAGCCATAACAAA
AGTCCAGTATGCTTTTTCACAGCATAACTGGACTGATTTCAGTTTACAACTATTCTGTCTAGTTTAAGACTTTATTG
TCATAGTTTAGATCTATTTTGTTCAGTTTAAGACTTTATTGTCCGCCCAC
TGTGGGCGGACAAAATAGTTGGGAACTGGGAGGGGTGGAAATGGAGTTTTTAAGGATTATTTAGGGAAGAGTGACAA
AATAGATGGGAACTGGGTGTAGCGTCGTAAGCTAATACGAAAATTAAAAATGACAAAATAGTTTGGAACTAGATTTC
ACTTATCTGGTTGTCGAGGTCGACATAACTTCGTATAATGTATGCTATACGAAGTTATCTCCATGAAGCTTTCTGAA
GTTCCTATACTTTCTAGAGAATAGGAACTTCGGAATAGGAACTTCAAAGCTTgatggccgccgcatgctcctctaga
ctcgatcgaggaattaattctaccgggtaggggaggcgcttttcccaaggcagtctggagcatgcgctttagcagcc
ccgctgggcacttggcgctacacaagtggcctctggcctcgcacacattccacatccaccggtaggcgccaaccggc
tccgttctttggtggccccttcgcgccaccttctactcctcccctagtcaggaagttcccccccgccccgcagctcg
cgtcgtgcaggacgtgacaaatggaagtagcacgtctcactagtctcgtgcagatggacagcaccgctgagcaatgg
aagcgggtaggcctttggggcagcggccaatagcagctttgctccttcgctttctgggctcagaggctgggaagggg
tgggtccgggggcgggctcaggggcgggctcaggggcggggcgggcgcccgaaggtcctccggaggcccggcattct
gcacgcttcaaaagcgcacgtctgccgcgctgttctcctcttcctcatctccgggcctttcgacctgttGACAATTA
ATCATCGGCATAGTATATCGGCATAGTATAATACGACTCACTATAGGAGGGCCACCATGGGATCGGCCATTGAA--//
                                                         M  G  S  A  I  E  -// EM7 promoter
PGK promoter
Tn7 left border 
A B
Figure 1. Structure of pGPS21loxFRTNeo. pGPS21loxFRTNeo was designed as a donor plasmid for transposase-mediated in vitro integration of a mammalian/
bacterialselectionmarkerandFRT,loxPsequences.Characteristicelementsoftheplasmidaresummarizedin(A).TheplasmidpossessesanR6Kg replicationorigin,
tetracycline resistance (TetR), and transposable elements having FRT-loxP-PGKp/EM7p-npt-FRT-loxP fragments. The fine structure of the transposable elements
is shown in (B), except for the middle part of the KAN/G418 resistance gene (npt). The loxP and FRT sequences are shown in closed and open boxes, respectively.
The PGK promoter and 30-termination sequence are indicated by lowercase letters. The EM7 promoter sequence is indicated by gray uppercase letters.
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targeting vectors
Plasmid pBSDT-AII has several characteristics to serve a
backbone function in the ﬁnal construct: the diphtheria
toxin A fragment gene (DT-A) driven by the viral MC-1 pro-
moterfunctionsasa negativeselectionmarker inEScells(15),
and there is a unique cloning site, BamHI, and sites for PmeI,
SacII, NotI, FseI and SrfI, which cut infrequently (Figure 3).
These provide anchors for restriction mapping of subcloned
genomic DNA and, more importantly, they will be unique cut-
ting sites for linearization of the ﬁnal construct prior to trans-
formation into ES cells. However, the introduction of DT-A
and MCS disrupted the coding sequence of the a-fragment of
b-galactosidase, and thus blue–white selection on X-gal/IPTG
plates is not possible. pBSDTA-II replicates via the ColE1/
pUC origin, and thus it is present as a multicopy plasmid in
E.coli and confers ampicillin resistance.
Creation of a floxed allele of mouse
mVam2/Vps41 gene
We have made several complex targeting constructs by use of
the developed plasmids shown above. Here, the strategy for
creating an mVam2/Vps41 gene knock-out allele is described
as an example (Figure 4). The yeast VAM2/VPS41 is required
for normal vacuolar morphogenesis (16–18), and its counter-
parts are found ubiquitously in mammals (19), higher plants,
as well as nematode and insect (20). In Drosophila, a mutation
of it causes defective eye pigmentation, and it is suggested to
be involved in vesicular trafﬁcking (21). We are interested in
the function of the mouse Vam2/Vps41 homologue (mVam2).
Because it is predicted to be involved in basic cellular func-
tions like vesicular trafﬁcking, a defect of it may result in
lethality in the earliest stages of development. We decided
to create a ﬂoxed allele that can be inactivated upon excision
by Cre recombinase expressed from cell type- and/or stage-
speciﬁc promoters or genetically modiﬁed adenovirus (22).
We identiﬁed a BAC clone containing a part of the mVam2
locus from a mouse 129Sv genomic library by PCR. A PCR
primer pair directed toward the 30-noncoding region of the
cDNA (GenBank accession no. ABB028843) gave a strong
signalofthe expectedsizeuponPCRanalysis(datanotshown)
from BAC clone 191m22 in the ES BAC library (Incyte
Genomics). The nucleotide sequences of both ends of the
BAC insert were determined and compared with a draft of
the mouse genome sequence. BAC 191m22 was not enough to
cover the entire region of mVam2, but contained the exon 13
to the last exon of the mVam2 locus (Figure 4). The overall
scheme of the construction is summarized in Figure 4.
BAC 191m22 was partially digested with Sau3AI, and then
the fractionated 10–15 kb fragments were cloned into the
BamHI site of pBSDT-AII (Figure 3). Ninety-six colonies
were subjected to direct PCR analysis to obtain three indi-
vidual clones containing exon 14 of mVam2. Through brief
restriction mapping and end-sequencing using primer DT-AR
or M13 Fwd23 (Table 1), we selected 324-4C/DT-A as a
suitable subclone for the construction.
Next, loxP was introduced into 324-4C/DT-A by means
of the in vitro transposition reaction. Plasmid 324-4C/DT-A
was incubated with pMODloxZeoDamp3 in the presence
of a modiﬁed Tn5-derived transposase (EZ::TN transposase;
Epicentre). The reaction products were introduced into E.coli
XL1-Blue by transformation, and 96 Zeo
R, Amp
S colonies
were isolated. Their plasmids were recovered and subjected
to sequencing using primer loxzeo-Cla or loxzeo-Nsi (Table 1
and Figure 2B) to determine the position and orientation of
each tagging site. The sequence information also veriﬁed the
structure and integrity of the subcloned fragment. Then, an
appropriate clone with the loxP-Zeo-loxP cassette in a desired
position and orientation, 324-4CDTAloxZeo-64, was selected.
Tn5 OE
EM7 promoter
Tn5 OE
CTGTCTCTTATACACATCTCAACCCTGAAGCTATCATAACTTCGTATAATGTATGCTATACGAAGTTATgtgtgtcagtt
agggtgtggaaagtccccaggctccccagcaggcagaagtatgcaaaggcacgtgttGACAATTAATCATCGGCATAGTA
TATCGGCATAGTATAATACGACTCACTATAGGAGGGCCACCATGGCCAAGTTGACCAGTGCCGTTCCGGTGCTCACCGCG
                                          M  A  K  L  T  S  A  V  P  V  L  T  A 
CGCGACGTCGCCGGAGCGGTCGAGTTCTGGACCGACCGGCTCGGGTTCTCCCGGGACTTCGTGGAGGACGACTTCGCCGG
 R  D  V  A  G  A  V  E  F  W  T  D  R  L  G  F  S  R  D  F  V  E  D  D  F  A  G
TGTGGTCCGGGACGACGTGACCCTGTTCATCAGCGCGGTCCAGGACCAGGTGGTGCCGGACAACACCCTGGCCTGGGTGT
  V  V  R  D  D  V  T  L  F  I  S  A  V  Q  D  Q  V  V  P  D  N  T  L  A  W  V
GGGTGCGCGGCCTGGACGAGCTGTACGCCGAGTGGTCGGAGGTCGTGTCCACGAACTTCCGGGACGCCTCCGGGCCGGCC
W  V  R  G  L  D  E  L  Y  A  E  W  S  E  V  V  S  T  N  F  R  D  A  S  G  P  A
ATGACCGAGATCGGCGAGCAGCCGTGGGGGCGGGAGTTCGCCCTGCGCGACCCGGCCGGCAACTGCGTGCACTTCGTGGC
 M  T  E  I  G  E  Q  P  W  G  R  E  F  A  L  R  D  P  A  G  N  C  V  H  F  V  A
CGAGGAGCAGGACTGACCGACGCCGACCAACACCGCCGGTCCGACGCGGCCCGACGGGTCCGAGGGGGGTCGACCTCGAA
  E  E  Q  D  *
ACTTGTTTATTGCAGCTTATAATGGTTACAAATAAAGCAATAGCATCACAAATTTCACAAATAAAGCATTTTTTTCACTG
CATTCTAGTTGTGGTTTGTCCAAACTCATCAATGTATCTTATCATGTCTGGATAACTTCGTATAATGTATGCTATACGAA
GTTATGATCGATGATGGTTGAGATGTGTATAAGAGACAG
A B
Tn5OE
Tn5OE
loxP loxP
EM7p
Zeo
A
m
p
pMODloxZeo  Amp3
(2868 bp)
ColE1 ori
loxzeo-Cla
loxzeo-Nsi
Figure 2. Structure of pMODloxZeoDAmp3. (A) The structure of pMODloxZeoDAmp3, which serves a transposable element having loxP sequences and
Zeocin-resistance marker. This plasmid does not confer ampicillin resistance because its bla gene is truncated, but does confer Zeocin resistance through EM7
promoter-Zeo cassette (B). The nucleotide sequence of the transposable segment is shown. The loxP sequences are indicated by solid boxes. The positions of
sequencing primers, lox-Cla and lox-Nsi were indicated by arrows.
e52 Nucleic Acids Research, 2005, Vol. 33, No. 5 PAGE 4 OF 8The plasmid was propagated in E.coli strain BH25.8 express-
ing Cre recombinase to remove the Zeo sequence and one
loxP. Cre-mediated excision was very efﬁcient: we found
100% removal in many experiments (data not shown).
The plasmid, 324-4CDTAloxDZeo-64, was recovered from
BH25.8 cells and propagated in DH10B cells, because the
quality and quantity of plasmids with BH25.8 cells was not
satisfactory, partly due to intermolecular recombination
between the loxP sites.
The ﬁnal step was introduction of the FRT-loxP-PGK/
EM7p-npt-FRT-loxP cassette into 324-4CDTAloxDZeo-64.
We performed the second round of the in vitro transposition
reaction in this step. Plasmid pGPS21loxFRTNeo was incub-
ated with 324-4CDTAloxDZeo-64 in the presence of a modi-
ﬁed T7 transposase and introduced into E.coli DH10B cells,
and selected on ampicillin and kanamycin. We picked up 96
Amp
R Kan
R colonies and then determined the tagging sites
by sequencing from both ends of the FRT-loxP-PGK/EM7p-
npt-FRT-loxP cassette. The position and orientation of each
insertion was determined by comparison with the genome
draft and assembled sequence obtained in step 3 (Figure 4).
We chose 324DTLN-F05 as the ﬁnal targeting vector. It has
a 4.2 kb uninterrupted homologous left arm and a short right
arm of 1.3 kb. The ﬁnal construct contains FRT-loxP-PGK/
EM7p-npt-FRT-loxP in intron 12, and the third loxP sequence
in intron 16. The expression of Flpe recombinase will remove
the positive selection marker, npt, leaving two loxP sites in
introns 12 and 16. This ﬂoxed allele can be inactivated by the
expression of Cre recombinase in particular tissues or devel-
opmental stages. The plasmid was puriﬁed by alkaline-lysis
and CsCl ultracentrifugation, linearized with PmeI at the
multiple cloning site of the pBSDT-AII backbone and then
electroporated into R1 embryonic stem cell (23). We identiﬁed
4 ES clones that underwent homologous recombination out
of 264 G418
R colonies on PCR analysis. These homologous
recombinants were introduced into blastocysts of C57Bl/6
mice and we obtained germ line transmitting chimeric mice.
The idea of the transposon-generated gene targeting con-
structs was reported ﬁrst by Westphal and Leder (12). We
applied the idea to create conditional knock-out constructs
that are indispensable for studying the function of genes
involved in basic cellular functions including organelle
assembly (24) or acidiﬁcation (25). The described plasmids
and transposons are components of the system applicable to
any gene of interest, and we could save time and effort in our
several ongoing gene targeting projects.
Figure 3. Structure of pBSDT-AII. Plasmid pBSDT-AII functions as the backbone for mouse targeting vectors. It has a unique multiple cloning site (MCS) and a
negative selection marker, diphtheria toxin-A fragment (DT-A), to be expressed in mammalian cells through the MC-1 promoter (MC-1p). This plasmid can be
propagatedincommonE.colistrainsinthepresenceofampicillin(Amp).ThenucleotidesequencearoundtheMCSandapartoftheDT-Acodingregionareshown.
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determined, there remain ambiguous segments scattering all
over the genome. The mVam2 locus, as well as the other genes
of our interests, is not assembled into contiguous sequence in
the public databases, but several contigs separated by highly
repetitive sequences. We avoid repeat sequences in the short
homologous arm of the ﬁnal targeting vector, because they are
practically impossible to amplify by PCR thus compromise
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Figure 4. Diagram of creation of a targeting construct using in vitro transposition reactions. The strategy for a floxed mVam2 allele is drawn schematically. Mouse
genomic DNA is indicated by thick lines and exons by vertical lines. The loxP and FRT elements are represented by closed and open triangles. In steps 1, 3 and 5,
the selected constructs are indicated by gray ovals.
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and orientation of tagging sites by sequencing the resultant
plasmids at steps 3 and 6 (Figure 4) using primers designed
to be annealed to the ends of transposons. The 96 clones gave
 90 reliable sequences of 400–500 bp, in each direction,
that cover almost all (10–20 kb) of the cloned segments in
both strands, thus we could verify the genomic structure at the
nucleotide sequence level.
In the case of the mVam2 gene targeting described here, we
ﬁrst subcloned a genomic segment from BAC into a plasmid,
pBSDT-AII,by’shot-gun’strategyinvolvingrestrictiondiges-
tion, size fractionation and ligation. Several groups developed
alternative highly efﬁcient strategies for retrieving a large
genomic DNA by homologous recombination in E.coli cells
having a bacterial or phage-derived recombination system
(26,27), and many excellent applications for engineering a
large genomic DNA has been developed to date (28–31).
We found that the use of such recombineering system elim-
inates in vitro DNA manipulations. In current projects, we
employ bacterial in vivo homologous recombination for step
1 of Figure 4, by using a PCR generated pBSDT-AII fragment
ﬂanked by 75 bp arms homologous to the ends of genomic
segment to be retrieved. However, we prefer the transposon-
mediated approach for insertion of FRT, loxP and neo gene
to the recombineering system, because we can obtain the
genomic structure of the locus as discussed above. In addition,
because many potential candidates having the neo cassette
with FRT and loxP at different position can be prepared
simultaneously (Figure 4, step 5), there are more choices
for assembling different targeting vectors without intensive
work. This versatility is an obvious advantage if one construct
fails to undergo homologous recombination in ES cells, which
is not a rare event in our experience.
While this study was under review, Zhang et al. (32) repor-
ted a similar strategy to introduce loxP and selectable markers
into targeting constructs by the use of Mu-based transposon.
Combination of their and our sets of transposons will be
possible because Mu, Tn5 and Tn7 can be integrated into
one contiguous DNA segment, adding further layer of gene
modiﬁcation strategy.
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